CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Humanwell Healthcare Group Co Ltd Company Snapshot
Humanwell Healthcare Group Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Humanwell Healthcare Group Co Ltd with three other companies in this sector in China: Jiangsu Hengrui Medicine Co., Ltd. (2015 sales of 9.32 billion Chinese Renmimbi [US$1.34 billion] of which 98% was Medicinal Manufacturing), Beijing Tongrentang Co., Ltd. (10.79 billion Chinese Renmimbi [US$1.56 billion] of which 51% was Manufacturing), and Shenzhen Neptunus Bioengineer (11.12 billion Chinese Renmimbi [US$1.60 billion] of which 85% was Pharmaceutical Distribution).

Sales Analysis. Humanwell Healthcare Group Co Ltd reported sales of 10.05 billion Chinese Renmimbi (US$1.45 billion) for the year ending December of 2015. This represents an increase of 42.5% versus 2014, when the company's sales were 7.05 billion Chinese Renmimbi. Sales at Humanwell Healthcare Group Co Ltd have increased during each of the previous five years (and since 2010, sales have increased a total of 356%). Sales of Medication and Health Products saw an increase of 44.7% in 2015, from 6.87 billion Chinese Renmimbi to 9.94 billion Chinese Renmimbi. Not all segments of Humanwell Healthcare Group Co Ltd experienced an increase in sales in 2015: sales of Other Main Operations fell 38.7% to 112.33 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Humanwell Healthcare Group Co Ltd
  Stock Performance Chart for Humanwell Healthcare Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 19.04
(Figures in Chinese Renmimbi)
1 Week -3.5%   13 Weeks -0.7%  
4 Weeks -9.2%   52 Weeks 9.9%  
 
Humanwell Healthcare Group Co Ltd Key Data:
  Ticker: 600079 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 10,045,984,874
(Year Ending Jan 2016).
Employees: 12,344
  Currency: Chinese Renmimbi Market Cap: 24,486,374,140
  Fiscal Yr Ends: December Shares Outstanding: 1,286,049,062
  Share Type: A Gu Closely Held Shares: 459,059,843
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.